How to Reduce Androgens in Females Naturally (PCOS/PMOS)

Natural changes can support general and metabolic health in PCOS, but evidence for androgen-related outcomes differs by intervention and by outcome.

Start with what you are trying to change. If your goal is a lower testosterone result, a lower-GI eating pattern and some other non-drug interventions have produced modest signals in studies. If your goal is less facial hair, clearer skin, preserved scalp hair, steadier cycles, or help conceiving, that same lab change may tell you very little.

The practical approach is to build eating and activity habits you can sustain, use direct care for the symptom that matters, and treat every tea or supplement as a separate evidence and safety decision. The studies reviewed below do not establish one food, exercise plan, tea, or supplement as a general natural androgen blocker for PCOS/PMOS.

First, recognize the exception

Seek urgent medical assessment if unwanted hair growth, acne, or scalp hair loss is new, severe, or rapidly worsening, especially with voice deepening, increased muscle mass, clitoral enlargement, or another sign of virilization. New-onset clinical or biochemical androgen excess after menopause, and markedly elevated androgen results, also warrant urgent assessment.

Those patterns can have causes outside PCOS. The current androgen-excess guideline uses the speed of change, virilization, biochemical severity, and assay quality to decide how urgently to investigate. It does not set one universal DHEAS cutoff because methods and reference ranges differ (Elhassan et al. 2025).

Confirm what the symptom or result means

Coarse terminal hair growth in an adult woman is a meaningful sign of possible androgen excess. Acne or female-pattern scalp hair loss on its own is a weaker predictor. These symptoms can justify assessment, but they cannot identify the source by themselves.

In adults, a PCOS/PMOS diagnosis generally requires two of three features after other causes have been excluded: clinical or biochemical androgen excess, ovulatory dysfunction, and polycystic ovarian morphology on ultrasound or an appropriate anti-Müllerian hormone result. The adolescent criteria are different. Acne, one flagged testosterone result, or an ultrasound image alone does not establish the diagnosis (Teede et al. 2023).

Total and free testosterone are the main biochemical tests used in a PCOS assessment. If they are not elevated, androstenedione and DHEAS may sometimes add information. Assay method matters. The combined oral contraceptive pill makes biochemical androgen assessment unreliable; if testing is imperative, a clinician may advise stopping it for at least three months while arranging another form of contraception. Do not stop it on your own. A clinician can also decide whether another condition needs to be excluded (Elhassan et al. 2025).

What the natural-intervention evidence actually shows

Most intervention evidence below comes from adults with PCOS or hirsutism. It cannot be generalized to every cause of androgen excess. The table keeps the population, hormone marker, patient-important outcome, and decision boundary separate because they answer different questions.

If you want to try a lower-GI structure, it does not require cutting out carbohydrates or following a branded PCOS diet. It can be as modest as choosing a higher-fiber carbohydrate source more often, such as beans or lentils in place of a refined grain, and deciding whether that change is practical enough to keep. Choose activity you can repeat rather than chasing an allegedly ideal intensity. These are ways to make a sustainable baseline concrete, not a promise that either change will fix an androgen-related symptom.

Choose the path by the outcome you want

Facial or body hair

Lowering a serum marker does not remove hair that has already become terminal. Temporary hair-removal methods, photoepilation, and electrolysis address existing hair directly. For someone not trying to conceive, the Endocrine Society guideline generally uses an appropriate combined oral contraceptive as initial pharmacologic treatment when medication is wanted, then considers an antiandrogen only with effective contraception and usually only after at least six months of inadequate response (Martin et al. 2018).

Acne or scalp hair loss

Acne and female-pattern hair loss can occur with or without a high serum androgen result and, in isolation, are relatively weak predictors of biochemical androgen excess. Assessment and symptom-specific care can proceed together. New, severe, or rapidly worsening androgen-related symptoms require further investigation rather than an arbitrary supplement trial (Elhassan et al. 2025; Teede et al. 2023).

Irregular cycles or metabolic health

The international guideline recommends lifestyle care even without weight loss. It considers metformin primarily for anthropometric and metabolic outcomes and prefers a combined oral contraceptive over metformin when hirsutism is the treatment target. If periods are very infrequent or absent for long stretches, discuss cycle regulation and endometrial protection with a clinician. Those decisions are separate from unwanted-hair treatment and metabolic care (2026 International PCOS/PMOS Guideline).

Trying to conceive

The hirsutism medication pathway changes when pregnancy is possible or desired. Antiandrogens require effective contraception because of fetal risk. For anovulatory infertility in PCOS without another infertility factor, current guidance uses letrozole as the first-line pharmacologic ovulation-induction option. That is a clinician-managed fertility pathway, not a general cycle supplement recommendation (Teede et al. 2023).

Do not assume that a product is safe while trying to conceive because it is natural. The same guideline treats inositol as experimental for fertility, with uncertain benefits and risks.

How to evaluate an “androgen blocker” formula

Ignore the category name long enough to answer six concrete questions:

• What exact ingredient and amount are in the current serving, not an old label, proprietary-blend total, or front-of-pack image?
• Was that ingredient studied in women with PCOS, or is the claim borrowed from cells, animals, men, or another condition?
• Did the study measure a laboratory marker or the symptom you want to change?
• Was the amount and preparation comparable, and was the result replicated?
• What did the comparator do, how long did the study run, and how many people completed it?
• Does pregnancy, trying to conceive, breastfeeding, medication use, or another health condition change the safety decision?

Defer a formula when its current label, dose, cited evidence, safety boundary, or purchase terms disagree. A corrected product page still cannot determine your personal fit. This standard applies to every formula, including ours.

Use this order: deal with an urgent exception first; name the outcome you want; build a sustainable eating and activity baseline; and, if you try an evidence-limited option, change one thing, confirm that it is safe in your context, and track the outcome rather than a marketing promise. If the result does not materialize, stop extending the protocol and choose care that directly addresses the symptom or fertility decision.